Edge Wealth Management Has Boosted Its Gilead Sciences (GILD) Stake; Eni S.p.A. (E) Covered By 0 Bulls

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Among 2 analysts covering Eni (NYSE:E), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Eni had 2 analyst reports since September 11, 2018 according to SRatingsIntel. Barclays Capital downgraded the stock to “Underweight” rating in Tuesday, September 11 report. See Eni S.p.A. (NYSE:E) latest ratings:

11/09/2018 Broker: Berenberg Rating: Hold Initiates Coverage On
11/09/2018 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Underweight Downgrade

Edge Wealth Management Llc increased Gilead Sciences Inc (GILD) stake by 4.68% reported in 2018Q3 SEC filing. Edge Wealth Management Llc acquired 4,552 shares as Gilead Sciences Inc (GILD)’s stock declined 6.92%. The Edge Wealth Management Llc holds 101,762 shares with $7.86M value, up from 97,210 last quarter. Gilead Sciences Inc now has $85.30B valuation. The stock increased 0.83% or $0.54 during the last trading session, reaching $65.94. About 9.05M shares traded or 12.11% up from the average. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 7.19% since February 14, 2018 and is downtrending. It has underperformed by 7.19% the S&P500. Some Historical GILD News: 08/05/2018 – The (new) top 10 pharma companies by 2017 revenue — adds Takeda/$SHPG plus $GILD; 09/03/2018 – Gilead TAF Sales Rise 5%, HIV Combo Pills Gain 5%; 21/05/2018 – ViiV Healthcare Will Market Dolutegravir/rilpivirine in All Countries in the European Union and European Economic Area; 27/04/2018 – European CHMP Adopts Positive Opinion for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide); 10/05/2018 – @JimCramer vets biotech giants Biogen, Celgene, Gilead and Regeneron for positive prospects; 16/03/2018 – Gilead TAF Sales Fall 3%, HIV Combo Pills Drop 3%; 15/05/2018 – U.S. Food and Drug Administration Approves Expanded lndication for Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents; 15/05/2018 – Geode Capital Adds Valeant, Exits pSivida, Buys More Gilead; 16/04/2018 – Gilead’s Complera Rises After 1-Wk Fall, Triumeq Advances: HIV; 14/05/2018 – Gilead’s Epclusa Falls After 3-Wk Rise, Mavyret Advances: Hep-C

More news for Eni S.p.A. (NYSE:E) were recently published by: Finance.Yahoo.com, which released: “Does McCormick & Company, Incorporated (NYSE:MKC) Have A Good P/E Ratio? – Yahoo Finance” on February 11, 2019. Finance.Yahoo.com‘s article titled: “Here’s How P/E Ratios Can Help Us Understand ESCO Technologies Inc. (NYSE:ESE) – Yahoo Sports” and published on January 17, 2019 is yet another important article.

Eni S.p.A. engages in the oil and gas, electricity generation and sale, and petrochemicals businesses. The company has market cap of $60.63 billion. The firm is involved in the oil and natural gas exploration, and field development and production activities, as well as liquefied natural gas activities in 44 countries, including Italy, Libya, Egypt, Norway, the United Kingdom, Angola, Congo, Nigeria, the United States, Kazakhstan, Algeria, Australia, Venezuela, Iraq, Ghana, and Mozambique. It has a 9 P/E ratio. It also supplies, trades, and markets gas and electricity; transports international gas; supplies crude oil; and refines and markets petroleum products at retail and wholesale markets primarily in Italy and rest of Europe.

The stock decreased 0.24% or $0.08 during the last trading session, reaching $33.4. About 87,090 shares traded. Eni S.p.A. (NYSE:E) has declined 2.78% since February 14, 2018 and is downtrending. It has underperformed by 2.78% the S&P500. Some Historical E News: 16/03/2018 – ENI CEO: TARGET ARE LARGE PROJECTS WITH SHORT TIME TO MARKET; 18/04/2018 – ENI CEO: EGYPT’S ZOHR CURRENT GROSS PRODUCTION 400MCFD; 10/03/2018 – MIDEAST – Factors to watch – March 11; 11/03/2018 – ENI SELLS 10% STAKE IN EGYPT’S ZOHR GAS PROJECT TO MUBADALA; 21/03/2018 – EXCLUSIVE-Rosneft, Eni fail to discover oil at Black Sea well; 16/03/2018 – ENI CEO: EXPLORATION IS 5-10 TIMES CHEAPER THAN BUYING RESERVES; 27/03/2018 – ENI CEO SAYS DOES NOT SEE ANY ISSUES WITH GAS SUPPLIES FROM RUSSIA , ENERGY SECURITY FOR ITALY DUE TO GEO-POLITICAL TENSIONS; 16/03/2018 – Eni to Propose 2018 Dividend to EUR0.83 Per Share; 18/04/2018 – Eni to Invest EUR7 Billion in Italy Over Next Four Years; 28/03/2018 – Shell files criminal complaint against ex-employee over Nigeria oilfield sale

Since September 4, 2018, it had 0 buys, and 4 insider sales for $14.65 million activity. 50,000 Gilead Sciences, Inc. (NASDAQ:GILD) shares with value of $3.56 million were sold by MARTIN JOHN C.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Nasdaq.com which released: “Health Care Sector Update for 02/12/2019: GILD,KMDA,OHI – Nasdaq” on February 12, 2019, also Nasdaq.com with their article: “Notable Friday Option Activity: WYNN, GS, GILD – Nasdaq” published on January 18, 2019, Nasdaq.com published: “Alphabet (GOOGL) Outperforms Estimates, Gilead (GILD) Mixed – Nasdaq” on February 04, 2019. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Nasdaq.com and their article: “Noteworthy ETF Outflows: XLV, JNJ, GILD, CVS – Nasdaq” published on February 13, 2019 as well as Nasdaq.com‘s news article titled: “Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know – Nasdaq” with publication date: January 23, 2019.

Investors sentiment increased to 0.89 in Q3 2018. Its up 0.14, from 0.75 in 2018Q2. It improved, as 43 investors sold GILD shares while 500 reduced holdings. 108 funds opened positions while 374 raised stakes. 963.01 million shares or 1.52% less from 977.84 million shares in 2018Q2 were reported. Goldman Sachs Group Inc Inc stated it has 0.19% in Gilead Sciences, Inc. (NASDAQ:GILD). Provident Invest Management owns 402,287 shares or 4.42% of their US portfolio. Oak Associate Limited Oh holds 1.11% or 234,494 shares. Renaissance Group Inc Ltd Liability holds 363,132 shares or 0.98% of its portfolio. Holt Cap Limited Liability Company Dba Holt Cap Prtn Limited Partnership reported 7,445 shares. Moreover, Essex Finance Services has 0.29% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 17,242 shares. Loring Wolcott Coolidge Fiduciary Advsr Ltd Liability Partnership Ma invested 0.05% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Merian Invsts (Uk) invested 0.04% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Tiger Mgmt holds 0.27% or 34,460 shares in its portfolio. Massachusetts-based Somerville Kurt F has invested 0.27% in Gilead Sciences, Inc. (NASDAQ:GILD). Archford Capital Strategies Limited Company holds 0.04% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 1,475 shares. Moreover, Rowland And Invest Counsel Adv has 0% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Commercial Bank Of Hawaii invested in 0.22% or 37,716 shares. Daiwa Sb reported 640 shares. Kornitzer Capital Incorporated Ks accumulated 174,160 shares.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart